Growth Potential
The Market Size for Our Drug Candidates and
The Global Herbal Medicine Market.
Market Overview
The global pharmaceutical market was valued at approximately $1.6 trillion in 2023, including an estimated $714 billion in U.S. sales. An industry projection estimated that the global market would grow from $1.585 trillion in 2022 to $2.401 trillion by 2029. The prevalence of chronic diseases and demand for prescription and over-the-counter products may contribute to market growth.
The global herbal medicine market was estimated at $185.86 billion in 2020 and projected to reach $430.05 billion by 2028, representing a projected compound annual growth rate of 11.32%. Interest in plant-derived products may contribute to this growth. This broad market includes consumer products and uses that differ from the drug candidates Stramsen Biotech Inc. is developing.
Markets Associated With Our Targeted Diseases
We are developing plant-based drug candidates for several therapeutic areas. The estimates below describe broad markets associated with those areas. They do not measure the market available to any individual candidate or indicate our potential revenue.
Cancer Therapeutics
The global cancer therapeutics market was valued at approximately $166.5 billion in 2021. Within this broad category, the prostate cancer therapeutics market was projected to exceed $24.9 billion by 2030, and the leukemia therapeutics market was projected to reach $20.49 billion by 2027. These estimates describe different market segments and should not be added together.
Chronic Kidney Disease
The global chronic kidney disease drugs market was estimated at $15.25 billion in 2019 and projected to reach $22.18 billion by 2026.
Diabetes
One projection estimated that the global type 2 diabetes market would reach $61.6 billion by 2030. A separate projection estimated that the broader diabetes drugs market would reach $78 billion by 2026. These categories overlap, so their estimates should not be combined.
Wound Healing
The global wound care market was estimated at $18.51 billion in 2022 and projected to reach $28.23 billion by 2029. This category includes products and services beyond those relevant to our wound care candidate.
Cardiovascular Disease
An earlier projection estimated that the cardiovascular disease drugs market would grow from $129.2 billion in 2015 to $146.4 billion by 2022. This historical projection covers multiple conditions and does not establish the current size of the market relevant to our candidates.
HIV
The global HIV drugs market was estimated at $30.46 billion in 2021 and projected to reach $45.58 billion by 2028.
Neuropathic Pain
The global neuropathic pain market was estimated at $6.3 billion in 2019 and projected to reach $9.8 billion by 2027.
Bone and Joint Health
The global bone and joint health ingredients market was estimated at $3.19 billion in 2021 and projected to reach $4.63 billion by 2027. This ingredients market is distinct from the market for approved treatments for bone and joint conditions.
These figures provide context for the therapeutic areas we are exploring. Our ability to serve any of these markets depends on the results of research and clinical development, regulatory approval, financing, manufacturing capabilities, competition and other factors. Market estimates vary by source and methodology and may change over time.
